NCT02212496
- Conditions
- Active Cancer, Cryptogenic Embolic Stroke
- Locations
-
- Samsung Medical Center Seoul, South Korea
Clinical trial condition
Explore clinical trials studying Cryptogenic Embolic Stroke. Study availability and eligibility vary by location and protocol.
NCT02212496